Company intelligence / Profile preview

Perspective Shifting

Coralville, Iowa, USAperspectiveshifters.com ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Perspective Therapeutics is developing Pb‑212-based targeted alpha-particle radiotherapies for cancer. Their approach uses proprietary peptides to deliver potent, short-range alpha radiation directly to tumor cells, aiming for higher efficacy and reduced toxicity compared to conventional radiotherapy. The company’s image-guided theranostics platform enables precise patient selection and treatment monitoring. Clinical programs are ongoing but specific trial results are not detailed in the search results

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalPeptidesSmall molecule (as chelators/conjugates)
Industry: Biotech

Beyond the preview

Go deeper on Perspective Shifting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perspective Shifting.

Explore the full profile